EveryLife Foundation Submits Comments on PDUFA VIII Reauthorization August 18, 2025 Share this page After compiling community input for the reauthorization of the Prescription Drug User Fee Act (PDUFA VIII), the EveryLife Foundation submitted comments reflecting our coalition’s shared priorities Legislative Proposals Patient-Focused Drug Development (PFDD) Rare Disease Innovation Hub Accelerated Approval FDA User Fees Related Articles The Updated Substantial Evidence Guidance September 28, 2026 Bipartisan Bill Introduced to Fund State Implementation of Newborn Screening Conditions September 25, 2026 Medical Frailty Tier System Guidance September 17, 2026 See All News